Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Hiroaki Sasaki

Hiroshima University Graduate School of Biomedical and Health Sciences

Japan

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

90%

Epidemiology

20%

Sars-cov-2

70%

Covid-19

40%

Vaccinology

30%

Antiretroviral Therapy

20%

Pandemic Studies

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

In vitro anti-severe acute respiratory syndrome coronavirus 2 effect of Ephedra przewalskii Stapf extract

Article Link

Year:

2024

Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan.

Article Link

Year:

2023

Earliest histopathological changes in COVID-19 pneumonia with comprehensive gene expression analyses: A case series study.

Article Link

Year:

2022

Clinical features and antimicrobial treatment of skin infections caused by Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus.

Article Link

Year:

2022

An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.

Article Link

Year:

2022

High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV

Article Link

Year:

2022

Comparison of the levels of neopterin, CRP, and IL-6 in patients infected with and without SARS-CoV-2

Article Link

Year:

2022

Intradermal Hepatitis B Vaccination in Non-Responder People Living with HIV in Japan.

Article Link

Year:

2022

Acute pancreatitis or severe increase in pancreatic enzyme levels following remdesivir administration in COVID-19 patients: an observational study.

Article Link

Year:

2022

Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximab.

Article Link

Year:

2021

Antibody response after COVID-19 vaccine BNT162b2 on health care workers in Japan

Article Link

Year:

2021

Collaborators4

Hiroshi Kaneko

Assistant Professor

Tokyo University of Pharmacy and Life Sciences

JAPAN

Kazuho Maeda

Yokohama National University

JAPAN

Taketoshi Mizutani

University of Tokyo

JAPAN

Hidemasa Nakaminami

Tokyo University of Pharmacy and Life Sciences

JAPAN

How do I reach out?

Meet Kite AI